Skip to main content

Table 3 Multivariate analysis for EOR, adjuvant therapy, and WHO classification of PFS

From: Clinical outcomes in central nervous system solitary-fibrous tumor/hemangiopericytoma: a STROBE-compliant single-center analysis

Aspects

p-value

HR

95% CI of OR

Adjuvant therapya

0.041

0.336

(0.118, 0.956)

EORa

0.034

0.378

(0.154, 0.927)

WHO grade

0.096

1.663

(0.914, 3.025)

  1. aEOR and adjuvant therapy were statistically significant in multivariate analysis